Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessRenin-angiotensin system inhibitor use and risk of Parkinson’s disease: a meta-analysis
Hypertension is a recognized risk factor for Parkinson’s disease (PD). The renin-angiotensin system (RAS) inhibitors are widely used to treat hypertension. However, the association of RAS inhibitor use with PD...